Research / HBIO / Fundamental state Inspectable configuration
State dimensions Filing 0001171843-25-003093 General Corporate
Debt relative to revenue 80th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
167.17% · OPTIONAL · VALID
Capex intensity 60th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.36% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.71% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-11.17% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 80th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
104.79% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
55.96% · CORE · VALID
Operating margin 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-228.11% · CORE · VALID
R&D intensity 40th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.66% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.76% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 16 states History building
Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 0/9 normalized Level 3 Mar 31, 2024 0/9 normalized Level 3 Jun 30, 2024 0/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 39.26%
Current 167.17%
Delta 127.91% Capex Intensity Decreased
Previous 2.81%
Current 2.36%
Delta -0.45% Cash Generation Increased
Previous 1.53%
Current 13.71%
Delta 12.18% Growth Increased
Previous -16.14%
Current -11.17%
Delta 4.97% Inventory Pressure Increased
Previous 24.69%
Current 104.79%
Delta 80.09% Margin Decreased
Previous 58.18%
Current 55.96%
Delta -2.22% Profitability Decreased
Previous -6.60%
Current -228.11%
Delta -221.51% R And D Intensity Decreased
Previous 11.05%
Current 10.66%
Delta -0.39% Sbc Intensity Decreased
Previous 4.61%
Current 2.76%
Delta -1.85% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.